Recce Pharmaceuticals Aktie News & Pressemeldungen

Noticias de Eulerpool Recce Pharmaceuticals

9/10/2024, 12:38:26

Recce Pharmaceuticals: Ein bedeutender Schritt in der Behandlung bakterieller Hautinfektionen

5/11/2024, 11:26:15

Fortschritte in der Behandlung bakterieller Hautinfektionen: Recce Pharmaceuticals in Phase-II-Studie auf Erfolgskurs

11/11/2024, 13:00:26

Revolutionäre Fortschritte bei der Behandlung des diabetischen Fußsyndroms mit RECCE® 327

10/12/2024, 10:20:50

Recce Pharmaceuticals erreicht bedeutenden Meilenstein mit Phase-3-Studie in Indonesien

17/2/2025, 14:14:19

Medizinische Innovation: Recce Pharmaceuticals begeistert mit Phase-II-Ergebnissen

Recce Pharmaceuticals Noticias de Acciones

Recce Pharmaceuticals es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Recce Pharmaceuticals.

27 de febrero ·
Yahoo
Recce Pharmaceuticals Granted Japanese Patent for RECCE® Anti-Infectives
10 de diciembre ·
Yahoo
Recce Pharmaceuticals Receives Approval from Indonesia’s Drug and Food Authority for Registrational Phase 3 Trial of RECCE® 327 Topical Gel in Diabetic Foot Infections
1 de diciembre ·
Yahoo
Investors in Recce Pharmaceuticals (ASX:RCE) have seen notable returns of 68% over the past five years
27 de noviembre ·
Yahoo
Recce Pharmaceuticals Granted Australia Patent for RECCE® Anti-Infectives
12 de noviembre ·
Yahoo
Recce Pharmaceuticals Receives Ethics Approval in Indonesia to Commence Registrational Phase 3 Trial of RECCE® 327 Topical Gel in Diabetic Foot Infections
6 de noviembre ·
Yahoo
Recce Pharmaceuticals Advances Patient Dosing to Final Stages in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
10 de octubre ·
Yahoo
Recce Pharmaceuticals Announces Recruitment Passes Halfway in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
6 de agosto ·
Yahoo
Recce Pharmaceuticals Announces Successful Completion of Share Purchase Plan
10 de julio ·
Yahoo
Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
1 de julio ·
Yahoo
Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327

Recce Pharmaceuticals Noticias de la acción

Recce Pharmaceuticals publica regularmente en la página web de la empresa noticias relevantes para los inversores.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Suscripción por 2 € / mes

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan